Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Ahlquist

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2006
Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasiaNeal K Osborn, Hongzhi Zou, Julian R Molina, et al.
Mayo Clinic Proceedings|April 12, 2021
Cost-Effectiveness of Multitarget Stool DNA Testing vs Colonoscopy or Fecal Immunochemical Testing for Colorectal Cancer Screening in Alaska Native PeopleDiana G Redwood, Tuan A Dinh, John B Kisiel, et al.
Gastrointestinal Endoscopy|April 30, 2017
Costs associated with Barrett's esophagus screening in the community: an economic analysis of a prospective randomized controlled trial of sedated versus hospital unsedated versus mobile community unsedated endoscopyJames P Moriarty, Nilay D Shah, Joel H Rubenstein, et al.
Mbio|February 20, 2020
Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer PathogenesisMinsuk Kim, Emily Vogtmann, David A Ahlquist, et al.
Journal of Molecular Biomarkers & Diagnosis|August 1, 2014
Methylated Bone Morphogenetic Protein 3 (BMP3) Gene: Evaluation of Tumor Suppressor Function and Biomarker Potential in Biliary CancerJohn B Kisiel, Jia Li, Hongzhi Zou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 22, 2016
Long-term Follow-up of Patients Having False-Positive Multitarget Stool DNA Tests after Negative Screening Colonoscopy: The LONG-HAUL Cohort StudyThomas G Cotter, Kelli N Burger, Mary E Devens, et al.
The American Journal of Gastroenterology|June 23, 2006
Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort studyPaul J Limburg, Robert A Vierkant, Zachary S Fredericksen, et al.
BMC Genomics|May 27, 2018
A Comprehensive Approach to Sequence-oriented IsomiR annotation (CASMIR): demonstration with IsomiR profiling in colorectal neoplasiaChung Wah Wu, Jared M Evans, Shengbing Huang, et al.
Plos One|January 28, 2014
Detection of colorectal serrated polyps by stool DNA testing: comparison with fecal immunochemical testing for occult blood (FIT)Russell I Heigh, Tracy C Yab, William R Taylor, et al.
Inflammatory Bowel Diseases|April 23, 2016
DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohn's Colitis: Implications for SurveillanceDavid H Johnson, William R Taylor, Mohammed M Aboelsoud, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2006
Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasiaNeal K Osborn, Hongzhi Zou, Julian R Molina, et al.
Mayo Clinic Proceedings|April 12, 2021
Cost-Effectiveness of Multitarget Stool DNA Testing vs Colonoscopy or Fecal Immunochemical Testing for Colorectal Cancer Screening in Alaska Native PeopleDiana G Redwood, Tuan A Dinh, John B Kisiel, et al.
Gastrointestinal Endoscopy|April 30, 2017
Costs associated with Barrett's esophagus screening in the community: an economic analysis of a prospective randomized controlled trial of sedated versus hospital unsedated versus mobile community unsedated endoscopyJames P Moriarty, Nilay D Shah, Joel H Rubenstein, et al.
Mbio|February 20, 2020
Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer PathogenesisMinsuk Kim, Emily Vogtmann, David A Ahlquist, et al.
Journal of Molecular Biomarkers & Diagnosis|August 1, 2014
Methylated Bone Morphogenetic Protein 3 (BMP3) Gene: Evaluation of Tumor Suppressor Function and Biomarker Potential in Biliary CancerJohn B Kisiel, Jia Li, Hongzhi Zou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 22, 2016
Long-term Follow-up of Patients Having False-Positive Multitarget Stool DNA Tests after Negative Screening Colonoscopy: The LONG-HAUL Cohort StudyThomas G Cotter, Kelli N Burger, Mary E Devens, et al.
The American Journal of Gastroenterology|June 23, 2006
Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort studyPaul J Limburg, Robert A Vierkant, Zachary S Fredericksen, et al.
BMC Genomics|May 27, 2018
A Comprehensive Approach to Sequence-oriented IsomiR annotation (CASMIR): demonstration with IsomiR profiling in colorectal neoplasiaChung Wah Wu, Jared M Evans, Shengbing Huang, et al.
Plos One|January 28, 2014
Detection of colorectal serrated polyps by stool DNA testing: comparison with fecal immunochemical testing for occult blood (FIT)Russell I Heigh, Tracy C Yab, William R Taylor, et al.
Inflammatory Bowel Diseases|April 23, 2016
DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohn's Colitis: Implications for SurveillanceDavid H Johnson, William R Taylor, Mohammed M Aboelsoud, et al.
Pageof 10